Details of the Drug
General Information of Drug (ID: DM72AT8)
Drug Name |
Proxyfan
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Proxyfan; proxifan; 3-(1H-imidazol-4-yl)propylphenylmethyl ether; 1H-Imidazole, 5-[3-(phenylmethoxy)propyl]-; AC1O4XL1; CHEMBL19173; GTPL1255; SCHEMBL4072620; SCHEMBL15929504; BDBM22915; CHEBI:93359; WNWALBVQAAIULR-UHFFFAOYSA-N; 4-(3-Benzyloxypropyl)-1H-imidazole; ZINC13813304; 5-[3-(benzyloxy)propyl]-1H-imidazole; 5-(3-phenylmethoxypropyl)-1H-imidazole; NCGC00159580-01; 4-[3-(phenylmethoxy)propyl]-3H-imidazole
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure | ||||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 216.28 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 2.1 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 6 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References